News Details

Rapid Advances in Diagnosis aiding Healthcare-associated Infection Diagnostics Market

Published date : Dec-2019

The growing demand for POC tests for HAI diagnosis will have a positive impact on the overall growth of the hospital-acquired infection diagnostics market


Arizton’s recent market research report on the global Healthcare-associated infectious disease diagnostics market provides comprehensive industry analysis, trend forecasts, and competitive analysis. The market study includes insights on segmentation by products (consumables and diagnostic analyzers/instruments devices), infections (urinary tract infections, surgical site infections, hospital-acquired pneumonia, bloodstream infections, and other healthcare-associated infections), tests (traditional diagnostics and molecular diagnostics), end-users (hospitals, clinics, ambulatory surgical centers (ASCs), and other end-users), and geography (North America, APAC, Europe, Latin America, and MEA).

The global hospital-acquired infection diagnostics market is expected to grow at a CAGR of over 8% during the period 2018–2024.

Request for your free sample now! 

Hospital-acquired Infection (HAIs) are infections that patients acquire while receiving treatment in healthcare/hospital settings. With significant improvements in modern healthcare infrastructure, service providers are regularly using several types of invasive devices and procedures to treat patients. As a result, infections can be associated with procedures such as surgeries and devices such as catheters and ventilators. Globally, HAIs are important causes of morbidity and mortality and are associated with a substantial increase in healthcare expenditure YOY.

The leading drivers and trends propelling the growth of the global hospital-acquired infection diagnostics market are discussed below:

Rapid Advances in Diagnosing and Treating HAIs

Technological advancements, especially in molecular diagnostics, POC diagnostics techniques, and immunoassays, have aided in treating and diagnosing several infection diseases. Technologies such as microfluidics, miniaturization, and the usage of software platforms, support the development and commercialization of decentralized diagnostics devices. These advanced devices have enabled healthcare professionals to perform accurate diagnostic testing, shorten result time, and allow direct billing for additional revenue. Vendors are launching innovative assay kits and panels, which significantly reduce testing time. This is expected to lead to hospital-acquired infection diagnostics market growth as the HAI patient population is immensely high.

High Growth Potential in Low and Middle-income Countries

According to the World Health Organization (WHO) data, 7 out of every 100 hospitalized patients in developed countries acquire at least acquire one HAI during their hospital stay. The number is higher in developing countries and stands at 10 per 100 patients. Globally, HAIs are a major burden in the medical industry. HAIs continue to cause significant morbidity, mortality, and added costs in healthcare settings. Half of all life-threatening hospital-acquired bloodstream infections and pneumonia occur in intensive care units (ICUs) despite ICUs representing only 15 to 20% of all hospital beds. The Centers for Disease Control and Prevention (CDC) estimates that 1 in every 20 hospitalized patients contracts HAI diseases. According to the WHO estimates, at any point in time, more than 1.4 million people are diagnosed with HAI diseases worldwide. Patients can acquire HAIs from exposure to bacteria, viruses, spores, or fungi from contact with healthcare worker’s hands, contaminated environmental surfaces, catheter insertions, and contact with other patients. Therefore, it is evident that the burden of HAIs is significantly high, which is contributing majorly to the growth of hospital-acquired infection diagnostics market globally.   

High Penetration of POC Testing

Point of Care (POC) testing offers significant benefits over traditional lab-based tests for diagnosing HAIs. For instance, patients admitted in ICUs and neonates in the neonatal intensive care could be benefitted as the test could be performed at the bedside and immediate results can be obtained, thereby fastening the decision aiming process. As the demand for POC tests is increasing at a healthy rate, vendors offer a wide range of real-time and rapid tests for diagnosing HAIs. Therefore, the growing demand for POC tests for HAI diagnosis will have a positive impact on the overall growth of the hospital-acquired infection diagnostics market during the forecast period.

Request for your free sample now!

Abbott, Becton Dickinson, bioMérieux, Danaher, Hoffmann-La Roche, Meridian Bioscience, QIAGEN are identified as the key vendors in the global hospital-acquired infection diagnostics market.

The complete overview of the latest market research report on the global healthcare associated infectious diseases market by Arizton is now available.

The report offers a detailed study of major trends, drivers, challenges and provides market sizing and forecast for major geographical regions and key countries.


About Arizton

Arizton – Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Mail: enquiry@arizton.com

Call:  +1-312-235-2040

          +1 302 469 0707

Support

+1-312-235-2040

Copyright 2019 - Arizton